Continuous documentation, qualified vehicles, staff training: the EU guidelines on “Good Distribution Practice” (GDP), amended in 2013, impose significantly greater obligations on manufacturers and freight forwarding companies dealing with pharmaceutical products. They transfer the already familiar principles of the Good Manufacturing Practices (GMP) from pharmaceutical manufacturing onto the streets.
Read on